Isu Abxis ranked among the top searched stocks on 11 days in the past month.
As of 11:31 AM on the 8th, Isu Abxis is trading at 10,950 KRW, up 5.8% from the previous day. This represents a 56.65% increase compared to February 4. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.
Today, foreigners are tentatively recorded as net sellers of 12,175 shares. Over the past five days, individual investors have net sold 118,761 shares, while foreigners and institutions have net sold 48,381 shares and net bought 161,258 shares, respectively.
On March 5, Isu Abxis became a market issue with the news "Gaucher disease treatment Abcertin completes Phase 1 clinical trial... stock price rises."
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
